Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Other
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Drug Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Drug Market Perspective (2018-2029)
2.2 OTC Anti-Infective Drug Growth Trends by Region
2.2.1 Global OTC Anti-Infective Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2018-2024)
2.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2024-2029)
2.3 OTC Anti-Infective Drug Market Dynamics
2.3.1 OTC Anti-Infective Drug Industry Trends
2.3.2 OTC Anti-Infective Drug Market Drivers
2.3.3 OTC Anti-Infective Drug Market Challenges
2.3.4 OTC Anti-Infective Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Drug Players by Revenue
3.1.1 Global Top OTC Anti-Infective Drug Players by Revenue (2018-2024)
3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2018-2024)
3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Drug Revenue
3.4 Global OTC Anti-Infective Drug Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2022
3.5 OTC Anti-Infective Drug Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Drug Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Drug Breakdown Data by Type
4.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2018-2024)
4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029)
5 OTC Anti-Infective Drug Breakdown Data by Application
5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2018-2024)
5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America OTC Anti-Infective Drug Market Size (2018-2029)
6.2 North America OTC Anti-Infective Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America OTC Anti-Infective Drug Market Size by Country (2018-2024)
6.4 North America OTC Anti-Infective Drug Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Drug Market Size (2018-2029)
7.2 Europe OTC Anti-Infective Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe OTC Anti-Infective Drug Market Size by Country (2018-2024)
7.4 Europe OTC Anti-Infective Drug Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Drug Market Size (2018-2029)
8.2 Asia-Pacific OTC Anti-Infective Drug Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2018-2024)
8.4 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Drug Market Size (2018-2029)
9.2 Latin America OTC Anti-Infective Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America OTC Anti-Infective Drug Market Size by Country (2018-2024)
9.4 Latin America OTC Anti-Infective Drug Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Drug Market Size (2018-2029)
10.2 Middle East & Africa OTC Anti-Infective Drug Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2018-2024)
10.4 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer OTC Anti-Infective Drug Introduction
11.1.4 Bayer Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK OTC Anti-Infective Drug Introduction
11.2.4 GSK Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva OTC Anti-Infective Drug Introduction
11.3.4 Teva Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Introduction
11.4.4 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 NOVARTIS
11.5.1 NOVARTIS Company Detail
11.5.2 NOVARTIS Business Overview
11.5.3 NOVARTIS OTC Anti-Infective Drug Introduction
11.5.4 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.5.5 NOVARTIS Recent Development
11.6 MYLAN
11.6.1 MYLAN Company Detail
11.6.2 MYLAN Business Overview
11.6.3 MYLAN OTC Anti-Infective Drug Introduction
11.6.4 MYLAN Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.6.5 MYLAN Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma OTC Anti-Infective Drug Introduction
11.7.4 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.7.5 Sun Pharma Recent Development
11.8 CR SANJIU
11.8.1 CR SANJIU Company Detail
11.8.2 CR SANJIU Business Overview
11.8.3 CR SANJIU OTC Anti-Infective Drug Introduction
11.8.4 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.8.5 CR SANJIU Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla OTC Anti-Infective Drug Introduction
11.9.4 Cipla Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.9.5 Cipla Recent Development
11.10 Lingrui
11.10.1 Lingrui Company Detail
11.10.2 Lingrui Business Overview
11.10.3 Lingrui OTC Anti-Infective Drug Introduction
11.10.4 Lingrui Revenue in OTC Anti-Infective Drug Business (2018-2024)
11.10.5 Lingrui Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global OTC Anti-Infective Drug Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Antifungal
Table 3. Key Players of Antibacterial
Table 4. Key Players of Antiviral
Table 5. Key Players of Antiseptics
Table 6. Key Players of Other
Table 7. Global OTC Anti-Infective Drug Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global OTC Anti-Infective Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 9. Global OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 10. Global OTC Anti-Infective Drug Market Share by Region (2018-2024)
Table 11. Global OTC Anti-Infective Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 12. Global OTC Anti-Infective Drug Market Share by Region (2024-2029)
Table 13. OTC Anti-Infective Drug Market Trends
Table 14. OTC Anti-Infective Drug Market Drivers
Table 15. OTC Anti-Infective Drug Market Challenges
Table 16. OTC Anti-Infective Drug Market Restraints
Table 17. Global OTC Anti-Infective Drug Revenue by Players (2018-2024) & (US$ Million)
Table 18. Global OTC Anti-Infective Drug Market Share by Players (2018-2024)
Table 19. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
Table 20. Ranking of Global Top OTC Anti-Infective Drug Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by OTC Anti-Infective Drug Revenue (CR5 and HHI) & (2018-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players OTC Anti-Infective Drug Product Solution and Service
Table 24. Date of Enter into OTC Anti-Infective Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global OTC Anti-Infective Drug Market Size by Type (2018-2024) & (US$ Million)
Table 27. Global OTC Anti-Infective Drug Revenue Market Share by Type (2018-2024)
Table 28. Global OTC Anti-Infective Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 29. Global OTC Anti-Infective Drug Revenue Market Share by Type (2024-2029)
Table 30. Global OTC Anti-Infective Drug Market Size by Application (2018-2024) & (US$ Million)
Table 31. Global OTC Anti-Infective Drug Revenue Market Share by Application (2018-2024)
Table 32. Global OTC Anti-Infective Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 33. Global OTC Anti-Infective Drug Revenue Market Share by Application (2024-2029)
Table 34. North America OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. North America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 36. North America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 37. Europe OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. Europe OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. Europe OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Asia-Pacific OTC Anti-Infective Drug Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 41. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2018-2024) & (US$ Million)
Table 42. Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2024-2029) & (US$ Million)
Table 43. Latin America OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Latin America OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 45. Latin America OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 46. Middle East & Africa OTC Anti-Infective Drug Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 47. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2018-2024) & (US$ Million)
Table 48. Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2024-2029) & (US$ Million)
Table 49. Bayer Company Detail
Table 50. Bayer Business Overview
Table 51. Bayer OTC Anti-Infective Drug Product
Table 52. Bayer Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 53. Bayer Recent Development
Table 54. GSK Company Detail
Table 55. GSK Business Overview
Table 56. GSK OTC Anti-Infective Drug Product
Table 57. GSK Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Teva Company Detail
Table 60. Teva Business Overview
Table 61. Teva OTC Anti-Infective Drug Product
Table 62. Teva Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 63. Teva Recent Development
Table 64. Johnson & Johnson Company Detail
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson OTC Anti-Infective Drug Product
Table 67. Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. NOVARTIS Company Detail
Table 70. NOVARTIS Business Overview
Table 71. NOVARTIS OTC Anti-Infective Drug Product
Table 72. NOVARTIS Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 73. NOVARTIS Recent Development
Table 74. MYLAN Company Detail
Table 75. MYLAN Business Overview
Table 76. MYLAN OTC Anti-Infective Drug Product
Table 77. MYLAN Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 78. MYLAN Recent Development
Table 79. Sun Pharma Company Detail
Table 80. Sun Pharma Business Overview
Table 81. Sun Pharma OTC Anti-Infective Drug Product
Table 82. Sun Pharma Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 83. Sun Pharma Recent Development
Table 84. CR SANJIU Company Detail
Table 85. CR SANJIU Business Overview
Table 86. CR SANJIU OTC Anti-Infective Drug Product
Table 87. CR SANJIU Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 88. CR SANJIU Recent Development
Table 89. Cipla Company Detail
Table 90. Cipla Business Overview
Table 91. Cipla OTC Anti-Infective Drug Product
Table 92. Cipla Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 93. Cipla Recent Development
Table 94. Lingrui Company Detail
Table 95. Lingrui Business Overview
Table 96. Lingrui OTC Anti-Infective Drug Product
Table 97. Lingrui Revenue in OTC Anti-Infective Drug Business (2018-2024) & (US$ Million)
Table 98. Lingrui Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global OTC Anti-Infective Drug Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global OTC Anti-Infective Drug Market Share by Type: 2022 VS 2029
Figure 3. Antifungal Features
Figure 4. Antibacterial Features
Figure 5. Antiviral Features
Figure 6. Antiseptics Features
Figure 7. Other Features
Figure 8. Global OTC Anti-Infective Drug Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global OTC Anti-Infective Drug Market Share by Application: 2022 VS 2029
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. OTC Anti-Infective Drug Report Years Considered
Figure 14. Global OTC Anti-Infective Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global OTC Anti-Infective Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global OTC Anti-Infective Drug Market Share by Region: 2022 VS 2029
Figure 17. Global OTC Anti-Infective Drug Market Share by Players in 2022
Figure 18. Global Top OTC Anti-Infective Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Anti-Infective Drug as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by OTC Anti-Infective Drug Revenue in 2022
Figure 20. North America OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 22. United States OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 26. Germany OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific OTC Anti-Infective Drug Market Share by Region (2018-2029)
Figure 34. China OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Japan OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. South Korea OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Southeast Asia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. India OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Australia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 42. Mexico OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Brazil OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa OTC Anti-Infective Drug Market Share by Country (2018-2029)
Figure 46. Turkey OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Saudi Arabia OTC Anti-Infective Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Bayer Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 49. GSK Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 50. Teva Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 51. Johnson & Johnson Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 52. NOVARTIS Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 53. MYLAN Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 54. Sun Pharma Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 55. CR SANJIU Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 56. Cipla Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 57. Lingrui Revenue Growth Rate in OTC Anti-Infective Drug Business (2018-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed